WoodTrust Financial Corp Invests $382,000 in Phreesia, Inc. (NYSE:PHR)

WoodTrust Financial Corp acquired a new position in Phreesia, Inc. (NYSE:PHRFree Report) during the 4th quarter, Holdings Channel.com reports. The institutional investor acquired 16,500 shares of the company’s stock, valued at approximately $382,000.

Several other hedge funds also recently made changes to their positions in the business. Envestnet Asset Management Inc. boosted its holdings in shares of Phreesia by 11.7% in the first quarter. Envestnet Asset Management Inc. now owns 9,692 shares of the company’s stock worth $255,000 after buying an additional 1,015 shares during the period. JPMorgan Chase & Co. boosted its holdings in shares of Phreesia by 160.9% in the first quarter. JPMorgan Chase & Co. now owns 85,546 shares of the company’s stock worth $2,254,000 after buying an additional 52,755 shares during the period. Raymond James Financial Services Advisors Inc. boosted its holdings in shares of Phreesia by 20.7% in the first quarter. Raymond James Financial Services Advisors Inc. now owns 8,427 shares of the company’s stock worth $222,000 after buying an additional 1,447 shares during the period. Bank of New York Mellon Corp boosted its holdings in shares of Phreesia by 0.9% during the first quarter. Bank of New York Mellon Corp now owns 219,598 shares of the company’s stock worth $5,788,000 after purchasing an additional 2,047 shares during the period. Finally, PNC Financial Services Group Inc. boosted its holdings in shares of Phreesia by 27.6% during the first quarter. PNC Financial Services Group Inc. now owns 16,059 shares of the company’s stock worth $424,000 after purchasing an additional 3,473 shares during the period. Institutional investors and hedge funds own 92.10% of the company’s stock.

Insider Buying and Selling at Phreesia

In other Phreesia news, General Counsel Allison C. Hoffman sold 1,316 shares of the business’s stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $24.55, for a total value of $32,307.80. Following the sale, the general counsel now owns 144,464 shares of the company’s stock, valued at approximately $3,546,591.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other news, CEO Chaim Indig sold 3,586 shares of the business’s stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $24.55, for a total value of $88,036.30. Following the sale, the chief executive officer now owns 1,280,410 shares in the company, valued at approximately $31,434,065.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, General Counsel Allison C. Hoffman sold 1,316 shares of the business’s stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $24.55, for a total transaction of $32,307.80. Following the completion of the sale, the general counsel now owns 144,464 shares in the company, valued at approximately $3,546,591.20. The disclosure for this sale can be found here. Insiders have sold 39,344 shares of company stock valued at $936,390 in the last 90 days. 5.80% of the stock is currently owned by company insiders.

Phreesia Stock Performance

Phreesia stock traded down $0.08 on Wednesday, hitting $22.80. The company’s stock had a trading volume of 178,057 shares, compared to its average volume of 526,786. The firm has a market cap of $1.29 billion, a P/E ratio of -9.08 and a beta of 0.92. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.02. The company has a fifty day moving average price of $25.14 and a 200-day moving average price of $20.91. Phreesia, Inc. has a one year low of $12.05 and a one year high of $34.98.

Phreesia (NYSE:PHRGet Free Report) last announced its quarterly earnings results on Thursday, March 14th. The company reported ($0.56) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.58) by $0.02. The firm had revenue of $95.00 million for the quarter, compared to analyst estimates of $93.52 million. Phreesia had a negative net margin of 38.42% and a negative return on equity of 53.33%. The business’s revenue for the quarter was up 24.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.72) EPS. On average, equities analysts anticipate that Phreesia, Inc. will post -1.46 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts recently commented on PHR shares. Canaccord Genuity Group raised their price target on shares of Phreesia from $36.00 to $37.00 and gave the stock a “buy” rating in a report on Friday, March 15th. Robert W. Baird lifted their target price on shares of Phreesia from $30.00 to $31.00 and gave the company an “outperform” rating in a research note on Monday, March 18th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $23.00 target price on shares of Phreesia in a research note on Thursday, March 21st. Truist Financial started coverage on shares of Phreesia in a research note on Monday, February 26th. They issued a “buy” rating and a $35.00 target price for the company. Finally, Stephens reissued an “overweight” rating and issued a $28.00 price target on shares of Phreesia in a research report on Friday, March 22nd. Two analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, Phreesia has a consensus rating of “Moderate Buy” and a consensus price target of $31.62.

View Our Latest Report on Phreesia

About Phreesia

(Free Report)

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

Read More

Want to see what other hedge funds are holding PHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phreesia, Inc. (NYSE:PHRFree Report).

Institutional Ownership by Quarter for Phreesia (NYSE:PHR)

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.